Cat.#: ACPP-1325
| Despition | Synaptotagmin 1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1129 | Recombinant Human GLP-1R Protein (Fc Tag) (AC1129) | 50 µg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1235 | C1orf187 Blocking Peptide (AC1235) | 250 µg | inquiry |
| ACPP-1414 | Human BEX1 Protein (AC1414) | 2 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
| ACPP-1660 | Mouse GDF7 Protein (AC1660) | 2 µg | inquiry |
| ACPP-1800 | Human RCN3 Protein (AC1800) | 5 µg | inquiry |
| ACPP-1391 | Human Apo D Protein (AC1391) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.